Subscribe to RSS
DOI: 10.4103/JLP.JLP_130_19
Expression of p57 immunomarker in the classification and differential diagnosis of partial and complete hydatidiform moles
Financial support and sponsorship Nil
Abstract
BACKGROUND: Hydatidiform mole (HM) is characterized histologically by cystic swelling of the chorionic villi, accompanied by variable trophoblastic proliferation. The most important reason for the correct recognition of moles is that they are associated with an increased risk of persistent trophoblastic disease (invasive mole) or choriocarcinoma.
AIMS AND OBJECTIVES: The aim of the study was to determine whether there is any role of p57 in differentiating partial and complete moles by immunohistochemical staining.
MATERIALS AND METHODS: A prospective observational study was undertaken in which 40 cases of molar pregnancy included over a period of 2 years. Detailed clinical and family histories were obtained from each patient. Histopathological examination followed by immunohistochemical study with p57 done in each case. Ultrasonography findings and serial titers of serum beta-human chorionic gonadotropin were noted whenever necessary.
RESULTS: Among the forty cases included, 25 (62%) had complete molar (CM) pregnancy, whereas the rest 15 (38%) had partial mole (PM). Both CM and PM were more pronounced in the age group of 20–25 years (44% and 60%, respectively), and among nulliparous women (68% and 70% respectively), 17 (42.5%) mothers had a prior history of abortion. In the histologically unequivocal cases of complete mole, 96% (24 of 25) did not express p57 and a single case was focal positive. In contrast, it was strongly and continuously expressed in both villous cytotrophoblast and stromal cells in all cases of PM (15 of 15).
CONCLUSION: p57 immunomarker is very helpful to diagnose and differentiate complete and partial HM.
Publication History
Received: 14 August 2019
Accepted: 21 August 2019
Article published online:
19 April 2020
© 2019.
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
-
References
- 1 Hui P, Buza N, Murphy KM, Ronnett BM. Hydatidiform moles: Genetic basis and precision diagnosis. Annu Rev Pathol 2017;12:449-85.
- 2 Samadder A, Kar R. Utility of p57 immunohistochemistry in differentiating between complete mole, partial mole and non-molar or hydropic abortus. Indian J Med Res 2017;145:133-7.
- 3 Lelic M, Fatusic Z, Iljazovic E, Ramic S, Markovic S, Alicelebic S, et al. Challenges in the routine praxis diagnosis of hydatidiform mole: A Tertiary health center experience. Med Arch 2017;71:256-60.
- 4 Madi JM, Braga A, Paganella MP, Litvin IE, Wendland EM. Accuracy of p57KIP2 compared with genotyping to diagnose complete hydatidiform mole: A systematic review and meta-analysis. BJOG 2018;125:1226-33.
- 5 Erol O, Suren D, Tutus B, Yararbas K, Sayiner A, Ozel MK, et al. Comparison of p57, c-erbB-2, CD117, and bcl-2 expression in the differential diagnosis of hydatidiform mole and hydropic abortion. Eur J Gynaecol Oncol 2016;37:522-9.
- 6 Triratanachat S, Nakaporntham P, Tantbirojn P, Shuangshoti S, Lertkhachonsuk R. Role of P57KIP2 immunohistochemical expression in histological diagnosis of hydatidiform moles. Asian Pac J Cancer Prev 2016;17:2061-6.
- 7 Ronnett BM. Hydatidiform moles: Ancillary techniques to refine diagnosis. Arch Pathol Lab Med 2018;142:1485-502.
- 8 Luchini C, Chilosi M, Manfrin E. The importance of immunohistochemistry in the differential diagnosis of molar disease. Pathologica 2016;108:151-3.
- 9 Colgan TJ, Noor A, Nanji S, Chang MC, Kolomietz E. Molecular diagnosis of placental hydatidiform mole: Innovation and outcomes. J Obstet Gynaecol Can 2017;39:1049-52.
- 10 Moussa RA, Eesa AN, Abdallah ZF, Abdelmeged A, Mahran A, Bahaa H, et al. Diagnostic utility of twist1, ki-67, and E-cadherin in diagnosing molar gestations and hydropic abortions. Am J Clin Pathol 2018;149:442-55.